Role of PI 3-kinase in angiopoietin-1-mediated migration and attachment-dependent survival of endothelial cells

Exp Cell Res. 1999 Dec 15;253(2):663-72. doi: 10.1006/excr.1999.4693.

Abstract

Angiopoietin-1 is a unique growth factor which induces Tie2 receptor autophosphorylation and interaction with signal transduction molecules, GRB2 and p85 subunit of PI 3-kinase, but no detectable mitogenic response. Here we show that PI 3-kinase-dependent activation of Akt and attachment to extracellular matrix are required for angiopoietin-1-mediated endothelial cell survival. Apoptosis of growth factor-deprived cells grown in monolayer was decreased by angiopoietin-1 and correlated with Akt activation. In contrast, angiopoietin-1, bFGF or VEGF failed to protect cells in suspension culture. Ceramide, an intermediate of several apoptotic pathways, interferes with growth factor-mediated Akt activation. Ceramide induced endothelial cell death and abolished angiopoietin-1-mediated activation of Akt and the effect on cell survival. In addition, we found that PI 3-kinase activity is necessary for migration of endothelial cells in response to Angiopoietin-1. A transient activation of MAPK/ERKs was also detected within 10 min after stimulation with angiopoietin-1. In contrast to VEGF-mediated biological effects, inhibition of MAPK/ERKs by PD98059 in endothelial cells did not affect angiopoietin-1 mediated survival or migration. These findings indicate significant differences in intracellular signaling between VEGF and angiopoietin-1 and that PI 3-kinase lipid products are key mediators of the biological effects of angiopoietin-1.

MeSH terms

  • Angiopoietin-1
  • Apoptosis / physiology
  • Cell Adhesion / physiology
  • Cell Movement / physiology*
  • Cell Survival / drug effects
  • Cell Survival / physiology
  • Chromones / pharmacology
  • Endothelial Growth Factors / pharmacology
  • Endothelium, Vascular / cytology*
  • Endothelium, Vascular / enzymology*
  • Enzyme Activation / drug effects
  • Enzyme Activation / physiology
  • Enzyme Inhibitors / pharmacology
  • Fibroblast Growth Factor 2 / pharmacology
  • Humans
  • Lymphokines / pharmacology
  • Membrane Glycoproteins / metabolism*
  • Mitogen-Activated Protein Kinases / metabolism
  • Morpholines / pharmacology
  • Phosphatidylinositol 3-Kinases / metabolism*
  • Protein Serine-Threonine Kinases / metabolism
  • Proto-Oncogene Proteins c-akt
  • Proto-Oncogene Proteins*
  • Sphingosine / analogs & derivatives
  • Sphingosine / pharmacology
  • Umbilical Veins / cytology
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors

Substances

  • Angiopoietin-1
  • Chromones
  • Endothelial Growth Factors
  • Enzyme Inhibitors
  • Lymphokines
  • Membrane Glycoproteins
  • Morpholines
  • N-acetylsphingosine
  • Proto-Oncogene Proteins
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors
  • Fibroblast Growth Factor 2
  • 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
  • AKT1 protein, human
  • Protein Serine-Threonine Kinases
  • Proto-Oncogene Proteins c-akt
  • Mitogen-Activated Protein Kinases
  • Sphingosine